Gastroparesis Risk and GLP-1 Clinical Trial Data Major clinical trials of semaglutide (SUSTAIN series) and tirzepatide (SURPASS series) monitored patients for gastroparesis-related symptoms across thousands of participants over 52 to 104 weeks
Glutathione treatment is considered the best natural option for individuals seeking lighter, brighter, and healthier skin
The pressure of a mattress, the weight of blankets, the texture of sheets, things you never noticed before suddenly demand attention
This triple mechanism distinguishes it from existing approved treatments such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GLP-1/GIP agonist)
US national surveys indicate that a significant proportion of Americans are not meeting the current recommended intakes for a number of micronutrients, including vitamin E, magnesium, vitamin A, and vitamin C